DOMTAR (UFS $91.84 rated Neutral with $105 up from $74 price target) HIGHER EBITDA ESTIMATES IN PERSONAL CARE SEGMENT, LOWER ESTIMATED YEAR END 2013 PENSION AND MEDICAL LIABILITIES, HIGHER LONG RUN OPERATING MARGINS IN PULP AND PAPER SEGMENT. 12/20/2013

DOMTAR (UFS $91.84 rated Neutral with $105 up from $74 price target) HIGHER
EBITDA ESTIMATES IN PERSONAL CARE SEGMENT, LOWER ESTIMATED
YEAR END 2013 PENSION AND MEDICAL LIABILITIES, HIGHER LONG RUN
OPERATING MARGINS IN PULP AND PAPER SEGMENT. 12/20/2013